AR034489A1 - A DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION. - Google Patents
A DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION.Info
- Publication number
- AR034489A1 AR034489A1 ARP020102240A ARP020102240A AR034489A1 AR 034489 A1 AR034489 A1 AR 034489A1 AR P020102240 A ARP020102240 A AR P020102240A AR P020102240 A ARP020102240 A AR P020102240A AR 034489 A1 AR034489 A1 AR 034489A1
- Authority
- AR
- Argentina
- Prior art keywords
- dry powder
- inhalation system
- powder inhalation
- transpulmonary administration
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
Abstract
Un nuevo sistema de inhalación de polvo seco adecuado para la administración transpulmonar. El sistema de inhalación de polvo seco de la presente está caracterizado porque usa una combinación de: un recipiente que aloja una composición liofilizada que contiene una sola dosis de un ingrediente activo, y tiene: (1) una forma tipo torta, no en polvo; (2) un índice de desintegración de 0,015 o más, y (3) una propiedad de convertirse en finas partículas que tienen un diámetro de partícula promedio de 10 micrones o menos o una fracción de partículas finas de 10% o más después de recibir un impacto de aire que tiene una velocidad de aire de por lo menos 1 m/seg y un caudal de aire de por lo menos 17 ml/seg; y un dispositivo que comprende elementos capaces de aplicar dicho impacto de aire a la composición liofilizada en dicho recipiente, y elementos para descargar la composición liofilizada en forma de polvo que ha sido convertida en partículas finas.A new dry powder inhalation system suitable for transpulmonary administration. The dry powder inhalation system herein is characterized in that it uses a combination of: a container that houses a lyophilized composition containing a single dose of an active ingredient, and has: (1) a cake-like, non-powdered form; (2) a decay index of 0.015 or more, and (3) a property of becoming fine particles having an average particle diameter of 10 microns or less or a fine particle fraction of 10% or more after receiving a air impact having an air velocity of at least 1 m / sec and an air flow rate of at least 17 ml / sec; and a device comprising elements capable of applying said air impact to the lyophilized composition in said container, and elements for discharging the lyophilized powder composition that has been converted into fine particles.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001182504 | 2001-06-15 | ||
JP2001400871 | 2001-12-28 | ||
JP2002111131 | 2002-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034489A1 true AR034489A1 (en) | 2004-02-25 |
Family
ID=40707472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102240A AR034489A1 (en) | 2001-06-15 | 2002-06-14 | A DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION. |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP4258647B2 (en) |
KR (1) | KR100815216B1 (en) |
AR (1) | AR034489A1 (en) |
HK (2) | HK1066748A1 (en) |
IL (1) | IL159080A (en) |
MY (1) | MY136601A (en) |
NO (1) | NO20131597L (en) |
PE (1) | PE20030189A1 (en) |
ZA (1) | ZA200309550B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006025884A1 (en) * | 2006-06-02 | 2007-12-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Adapter with a connector for a nebulizer |
EP2043717A1 (en) * | 2006-07-14 | 2009-04-08 | Astra Zeneca AB | Inhalation system and delivery device for the administration of a drug in the form of dry powder |
EP2082762A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
KR102077790B1 (en) * | 2018-04-18 | 2020-02-14 | 라이프리버 주식회사 | Powder spray device in which the spray amount is controllable |
TWI812509B (en) * | 2022-10-17 | 2023-08-11 | 國立成功大學 | Functional powder delivery device and system thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0464878A (en) * | 1990-07-04 | 1992-02-28 | Mitsubishi Heavy Ind Ltd | Absorber for absorption refrigerating machine |
JPH06186141A (en) * | 1992-12-16 | 1994-07-08 | Hitachi Ltd | Remaining stress prediction method |
TW403653B (en) * | 1995-12-25 | 2000-09-01 | Otsuka Pharma Co Ltd | Dry compositions |
-
2002
- 2002-06-14 PE PE2002000514A patent/PE20030189A1/en not_active Application Discontinuation
- 2002-06-14 AR ARP020102240A patent/AR034489A1/en active IP Right Grant
- 2002-06-14 KR KR1020037016433A patent/KR100815216B1/en not_active IP Right Cessation
- 2002-06-14 MY MYPI20022231A patent/MY136601A/en unknown
-
2003
- 2003-11-27 IL IL159080A patent/IL159080A/en not_active IP Right Cessation
- 2003-12-09 ZA ZA2003/09550A patent/ZA200309550B/en unknown
-
2004
- 2004-08-16 JP JP2004236727A patent/JP4258647B2/en not_active Expired - Fee Related
- 2004-12-08 HK HK04109711.5A patent/HK1066748A1/en not_active IP Right Cessation
-
2009
- 2009-06-17 HK HK09105444.2A patent/HK1127567A1/en not_active IP Right Cessation
-
2013
- 2013-12-03 NO NO20131597A patent/NO20131597L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20131597L (en) | 2004-02-12 |
HK1127567A1 (en) | 2009-10-02 |
JP2004329962A (en) | 2004-11-25 |
ZA200309550B (en) | 2005-02-23 |
HK1066748A1 (en) | 2005-04-01 |
KR100815216B1 (en) | 2008-03-19 |
KR20040069978A (en) | 2004-08-06 |
PE20030189A1 (en) | 2003-03-12 |
MY136601A (en) | 2008-10-31 |
JP4258647B2 (en) | 2009-04-30 |
IL159080A (en) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210425A (en) | Dry powder inhalation system for transpulmonary administration | |
ME00220B (en) | Stable pharmaceutical solution formulations for pressurised metered dose inhalers | |
ES2193726T3 (en) | MEDICINAL AEROSOL FORMULATIONS. | |
DE60313587D1 (en) | DRUG DELIVERY AND PACKAGING | |
CO6280410A2 (en) | DOSING DEVICE FOR INHALING A PULVERULENT SUBSTANCE | |
ECSP088403A (en) | PHARMACEUTICAL FORMULATION OF ORAL ABSORPTION AND ITS METHOD OF ADMINISTRATION | |
WO2006008517A3 (en) | Use of dry powder compositions for pulmonary delivery | |
HRP20000867B1 (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
PA8633401A1 (en) | INHALING DRUG DEVICE | |
TR200101442T2 (en) | Pharmaceutical aeorosol composition containing HFA 227 and HFA 137 | |
BR112013001030B8 (en) | droplet generating device for use in delivering a volume of ophthalmic fluid to a subject's eye | |
PT1294421E (en) | Dry powder inhaler | |
AR051252A1 (en) | POWDER INHALER WITH VARIOUS CHANNEL TOWEL | |
BR0114140A (en) | Continuous Dry Powder Inhaler | |
WO2004100872A3 (en) | Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin | |
BR0303348A (en) | Aerosol formulations for pulmonary drug delivery to produce systemic effect | |
WO2005084638A3 (en) | Formulations decreasing infectivity of pulmonary diseases | |
NO20025873L (en) | Very effective delivery of a large therapeutic amount of aerosol | |
WO2004060433A3 (en) | Delivery devices | |
EA200801767A1 (en) | PHARMACEUTICAL COMPOSITION FOR AEROSOL SPRAYING WITH TWO ACTING SUBSTANCES AND AT LESS THAN ONE SURFACE ACTIVE SUBSTANCE | |
CU22838A3 (en) | COMPOSITIONS TO CONTROL BACTERIAL COLONIZATION | |
AR034489A1 (en) | A DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION. | |
AR042453A1 (en) | A LIOFILIZED INTERFERON-GAMMA COMPOSITION FOR TRANSPULMONARY ADMINISTRATION AND A SYSTEM FOR INHALATION | |
ECSP034905A (en) | DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION | |
EP4159208A1 (en) | Compositions and methods for the prophylaxis of an infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |